메뉴 건너뛰기




Volumn 39, Issue 9, 2009, Pages 656-662

Comparison of intrinsic metabolic clearance in fresh and cryopreserved human hepatocytes

Author keywords

Cryopreserved; Drug development; Drug metabolism; Fresh; Human hepatocytes; Intrinsic clearance

Indexed keywords

BUFURALOL; DIAZEPAM; DICLOFENAC; MIDAZOLAM; PHENACETIN; UMBELLIFERONE; DRUG;

EID: 70350496617     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.1080/00498250902974229     Document Type: Article
Times cited : (28)

References (19)
  • 1
    • 0038278508 scopus 로고    scopus 로고
    • An update on in vitro test methods in human hepatic drug biotransformation research: Pros and cons
    • Brandon EF, Raap CD, Meijerman I, Beijnen JH, Schellens JH. (2003). An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol Appl Pharmacol 189:233-246
    • (2003) Toxicol Appl Pharmacol , vol.189 , pp. 233-246
    • Brandon, E.F.1    Raap, C.D.2    Meijerman, I.3    Beijnen, J.H.4    Schellens, J.H.5
  • 2
    • 0037272197 scopus 로고    scopus 로고
    • Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: Focus on in vitro studies
    • Donato MT, Castell JV. (2003). Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: focus on in vitro studies. Clin Pharmacokinet 42:153-178
    • (2003) Clin Pharmacokinet , vol.42 , pp. 153-178
    • Donato, M.T.1    Castell, J.V.2
  • 3
    • 11244269638 scopus 로고    scopus 로고
    • Use of a cocktail of probe substrates for drug-metabolizing enzymes for the assessment of the metabolic capacity of hepatocyte preparations
    • Floby E, Briem S, Terelius Y, Sohlenius-Sternbeck A-K. (2004). Use of a cocktail of probe substrates for drug-metabolizing enzymes for the assessment of the metabolic capacity of hepatocyte preparations. Xenobiotica 34:949-959
    • (2004) Xenobiotica , vol.34 , pp. 949-959
    • Floby, E.1    Briem, S.2    Terelius, Y.3    Sohlenius-Sternbeck, A.-K.4
  • 4
    • 44349148749 scopus 로고    scopus 로고
    • The role of hepatic transporters in drug elimination
    • Funk C. (2008). The role of hepatic transporters in drug elimination. Exp Opinion Drug Metab Toxicol 4:363-379
    • (2008) Exp Opinion Drug Metab Toxicol , vol.4 , pp. 363-379
    • Funk, C.1
  • 5
    • 40749102194 scopus 로고    scopus 로고
    • Prediction of metabolic clearance using fresh human hepatocytes: Comparison with cryopreserved hepatocytes and hepatic microsomes for five benzodiazepines
    • Hallifax D, Galetin A, Houston JB. (2008). Prediction of metabolic clearance using fresh human hepatocytes: comparison with cryopreserved hepatocytes and hepatic microsomes for five benzodiazepines. Xenobiotica 38:353-367
    • (2008) Xenobiotica , vol.38 , pp. 353-367
    • Hallifax, D.1    Galetin, A.2    Houston, J.B.3
  • 8
    • 0028342648 scopus 로고
    • Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance
    • Houston JB. (1994). Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem Pharmacol 47:1469-1479
    • (1994) Biochem Pharmacol , vol.47 , pp. 1469-1479
    • Houston, J.B.1
  • 10
    • 34247505574 scopus 로고    scopus 로고
    • Human hepatocytes: Isolation, cryopreservation and applications in drug development
    • Li AP. (2007). Human hepatocytes: isolation, cryopreservation and applications in drug development. Chem-Biol Interact 168:16-29.
    • (2007) Chem-Biol Interact , vol.168 , pp. 16-29
    • Li, A.P.1
  • 11
    • 0032968777 scopus 로고    scopus 로고
    • Cryopreserved human hepatocytes: Characterization of drugmetabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential
    • Li AP, Lu C, Brent JA, Pham C, Fackett A, Ruegg CE, Silber PM. (1999). Cryopreserved human hepatocytes: characterization of drugmetabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. Chem Biol Interact 121:17-35.
    • (1999) Chem Biol Interact , vol.121 , pp. 17-35
    • Li, A.P.1    Lu, C.2    Brent, J.A.3    Pham, C.4    Fackett, A.5    Ruegg, C.E.6    Silber, P.M.7
  • 12
    • 0030726508 scopus 로고    scopus 로고
    • Preclinical evaluation of drug-drug interaction potential: Present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction
    • Li AP, Maurel P, Gomez-Lechon MJ, Cheng LC, and Jurima-Romet M. (1997). Preclinical evaluation of drug-drug interaction potential: present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction. Chem- Biol Interact 107:5-16.
    • (1997) Chem- Biol Interact , vol.107 , pp. 5-16
    • Li, A.P.1    Maurel, P.2    Gomez-Lechon, M.J.3    Cheng, L.C.4    Jurima-Romet, M.5
  • 13
    • 6944226371 scopus 로고    scopus 로고
    • Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance
    • McGinnity DF, Soars MG, Urbanowicz RA, Riley RJ. (2004). Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance. Drug Metab Dispos 32:1247-1253
    • (2004) Drug Metab Dispos , vol.32 , pp. 1247-1253
    • McGinnity, D.F.1    Soars, M.G.2    Urbanowicz, R.A.3    Riley, R.J.4
  • 14
    • 0037403950 scopus 로고    scopus 로고
    • Utility of hepatocytes in predicting drug metabolism: Comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro
    • Naritomi Y, Terashita S, Kagayama A, Sugiyama Y. (2003). Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro. Drug Metab Dispos 31:580-588
    • (2003) Drug Metab Dispos , vol.31 , pp. 580-588
    • Naritomi, Y.1    Terashita, S.2    Kagayama, A.3    Sugiyama, Y.4
  • 15
    • 34249006024 scopus 로고    scopus 로고
    • Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo
    • Soars MG, Grime K, Sproston JL, Webborn PJ, Riley RJ. (2007a). Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo. Drug Metab Dispos 35:859-865
    • (2007) Drug Metab Dispos , vol.35 , pp. 859-865
    • Soars, M.G.1    Grime, K.2    Sproston, J.L.3    Webborn, P.J.4    Riley, R.J.5
  • 17
    • 26644473648 scopus 로고    scopus 로고
    • Impaired glutathioneconjugating capacity by cryopreserved human and rat hepatocytes
    • Sohlenius-Sternbeck A-K, Schmidt S. (2005). Impaired glutathioneconjugating capacity by cryopreserved human and rat hepatocytes. Xenobiotica 35:727-36.
    • (2005) Xenobiotica , vol.35 , pp. 727-736
    • Sohlenius-Sternbeck, A.-K.1    Schmidt, S.2
  • 18
    • 33947360643 scopus 로고    scopus 로고
    • Reduced glutathione levels and expression of the enzymes of glutathione synthesis in cryopreserved hepatocyte monolayer cultures
    • Stevenson DJ, Morgan C, McLellan LI, Grant MH. (2007). Reduced glutathione levels and expression of the enzymes of glutathione synthesis in cryopreserved hepatocyte monolayer cultures. Toxicol in Vitro 21:527-532
    • (2007) Toxicol in Vitro , vol.21 , pp. 527-532
    • Stevenson, D.J.1    Morgan, C.2    McLellan, L.I.3    Grant, M.H.4
  • 19
    • 0031753740 scopus 로고    scopus 로고
    • Metabolic activity of fresh and cryopreserved dog hepatocyte suspensions
    • Swales NJ, Utesch D. (1998). Metabolic activity of fresh and cryopreserved dog hepatocyte suspensions. Xenobiotica 28:937-948
    • (1998) Xenobiotica , vol.28 , pp. 937-948
    • Swales, N.J.1    Utesch, D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.